The Georgia Medical Cannabis Society (GMCS) creates connections among patients, caregivers, healthcare professionals, researchers, advocates, and policymakers who might otherwise approach medical cannabis from separate corners. Through education, public forums, patient support, and policy engagement, GMCS gives Georgia’s medical cannabis community a place to learn from one another, share concerns, and work toward practical improvements in patient access and safety.
For patients, one of the organization’s central priorities is helping people understand where they can legally obtain tested medical cannabis products and why that distinction matters. When a state medical program offers too few qualifying conditions, too few product forms, or too little public information, patients may be pushed toward unregulated sources where product contents, potency, contaminants, and manufacturing practices are unknown. GMCS works to reduce that risk by educating patients and the broader community about Georgia’s regulated medical cannabis system and the licensed dispensaries where patients can obtain legal products.
That education is paired with policy engagement. GMCS works with legislators and other decision-makers to explain where Georgia’s medical cannabis program is falling short for patients and why a more robust program can itself be a public safety strategy. Expanding appropriate qualifying conditions and product options gives more patients a realistic pathway to stay within the regulated medical system rather than relying on street markets or products that haven't met the state’s safety requirements.
That work became especially significant in 2026, when Georgia enacted SB 220, the “Putting Georgia’s Patients First Act.” The law moved Georgia beyond its earlier low-THC-oil framework by expanding authorized medical cannabis forms to include raw plant material and vaporization, adding qualifying conditions, and making other changes to the state program. For an organization that has educated both patients and lawmakers about the need for safer, more practical access, the change represents an important expansion of the regulated pathway available to Georgia patients.
The Georgia Medical Cannabis Society’s nomination captures what the Community Catalyst Award is intended to recognize: an organization that builds bridges among people who experience the medical cannabis system differently and turns those connections into better information, stronger patient support, and policy change. By helping patients find regulated products, helping healthcare professionals and communities better understand the program, and helping lawmakers hear directly about access gaps, GMCS strengthens cannabis safety through collaboration.
Website: Georgia Medical Cannabis Society
Support Georgia Medical Cannabis Society for the 2026 Community Catalyst Award.
If you appreciate ASA's work, sign up for alerts and updates, and make a donation to support ASA's vital mission.
Share this page
